浅岡 忠史

<p>Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response</p>. 

International journal of oncology 68(3) 2026年3月  

Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma. 

Cancer immunology, immunotherapy : CII 75(1) 20-20 2025年12月19日  

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma 

Scientific Reports 15(1) 2025年11月12日  

Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular Carcinoma. 

Cancer science 2025年8月27日  

Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations. 

Annals of surgical oncology 2025年5月30日  

A Case of Ascending Colon Perivascular Epithelioid Cell Tumor Presenting with Intestinal Intussusception: Case Report. 

Surgical case reports 11(1) 2025年  

Clinical and Pathological Analysis of Perianal Paget's Disease: A Case Report and Review of 89 Cases. 

Cancer diagnosis & prognosis 5(1) 49-55 2025年  

ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Patients with Pancreatic Cancer, and Enhances Radioresistance. 

Annals of surgical oncology 2024年9月19日  

miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. 

Annals of surgical oncology 2024年9月13日  

Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis. 

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2024年9月10日  

Preoperative nutritional status is a useful predictor of the feasibility of postoperative treatment in octogenarian-plus pancreatic ductal adenocarcinoma patients. 

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 50(12) 108650-108650 2024年9月4日  

Prognostic impact of aberrant right hepatic artery involvement in patients with pancreatic cancer: A multicenter retrospective cohort study. 

Journal of surgical oncology 130(3) 504-515 2024年9月  

ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma. 

Annals of surgical oncology 31(8) 5000-5001 2024年8月  

The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma. 

Cancer letters 595 216997-216997 2024年7月28日  

Apparent diffusion coefficient in intrahepatic cholangiocarcinoma diffusion-weighted magnetic resonance imaging noninvasively predicts Ki-67 expression. 

Hepatology research : the official journal of the Japan Society of Hepatology 54(7) 678-684 2024年7月  

Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma. 

Annals of surgical oncology 31(6) 3718-3736 2024年6月  

ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015) 

Annals of Surgical Oncology 31(8) 5215-5216 2024年5月25日  

ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)? 

Annals of Surgical Oncology 31(7) 4702-4703 2024年5月9日  

ASO Visual Abstract: Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma. 

Annals of surgical oncology 2024年5月3日  

Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. 

Scientific reports 14(1) 10199-10199 2024年5月3日